IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

InMed Pharmaceuticals

CUSIP: 457637106 | 1 institutional holders

Quarters

Q1 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2018

AlphaMark Advisors, LLC72
0.0% of portfolio›$0
StyleTurnoverLocationFiled
AlphaMark Advisors, LLC
72$00.0%GrowthVery LowFort Mitchell, KY2018-05-09